Guardant Health (GH) Competitors $50.25 -1.04 (-2.03%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$50.17 -0.08 (-0.16%) As of 07/11/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GH vs. VCYT, NTRA, HIMS, OPCH, RDNT, BTSG, SHC, SGRY, CON, and PRVAShould you be buying Guardant Health stock or one of its competitors? The main competitors of Guardant Health include Veracyte (VCYT), Natera (NTRA), Hims & Hers Health (HIMS), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry. Guardant Health vs. Its Competitors Veracyte Natera Hims & Hers Health Option Care Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Concentra Group Holdings Parent Privia Health Group Guardant Health (NASDAQ:GH) and Veracyte (NASDAQ:VCYT) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability. Does the media prefer GH or VCYT? In the previous week, Guardant Health had 5 more articles in the media than Veracyte. MarketBeat recorded 8 mentions for Guardant Health and 3 mentions for Veracyte. Guardant Health's average media sentiment score of 1.47 beat Veracyte's score of 0.93 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Veracyte 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, GH or VCYT? Veracyte has lower revenue, but higher earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$739.02M8.42-$436.37M-$3.39-14.82Veracyte$463.39M4.58$24.14M$0.4166.05 Do institutionals and insiders believe in GH or VCYT? 92.6% of Guardant Health shares are held by institutional investors. 6.1% of Guardant Health shares are held by company insiders. Comparatively, 1.4% of Veracyte shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is GH or VCYT more profitable? Veracyte has a net margin of 7.13% compared to Guardant Health's net margin of -53.82%. Veracyte's return on equity of 6.14% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Guardant Health-53.82% N/A -26.77% Veracyte 7.13%6.14%5.60% Which has more risk & volatility, GH or VCYT? Guardant Health has a beta of 1.44, indicating that its stock price is 44% more volatile than the S&P 500. Comparatively, Veracyte has a beta of 2.07, indicating that its stock price is 107% more volatile than the S&P 500. Do analysts recommend GH or VCYT? Guardant Health currently has a consensus target price of $53.76, indicating a potential upside of 6.99%. Veracyte has a consensus target price of $40.90, indicating a potential upside of 51.03%. Given Veracyte's higher possible upside, analysts plainly believe Veracyte is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 0 Sell rating(s) 0 Hold rating(s) 21 Buy rating(s) 0 Strong Buy rating(s) 3.00Veracyte 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70 SummaryGuardant Health and Veracyte tied by winning 8 of the 16 factors compared between the two stocks. Get Guardant Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GH vs. The Competition Export to ExcelMetricGuardant HealthMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.23B$2.94B$5.56B$9.11BDividend YieldN/A2.42%5.06%4.01%P/E Ratio-14.8220.8528.2620.26Price / Sales8.42300.55435.95101.33Price / CashN/A42.1137.1257.67Price / Book-44.477.638.045.49Net Income-$436.37M-$55.05M$3.19B$250.45M7 Day PerformanceN/A8.43%3.62%4.78%1 Month Performance1.95%8.14%5.98%9.58%1 Year Performance61.73%1.62%29.39%16.41% Guardant Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GHGuardant Health4.116 of 5 stars$50.25-2.0%$53.76+7.0%+61.7%$6.23B$739.02M-14.822,021VCYTVeracyte3.5949 of 5 stars$26.34-4.3%$40.90+55.3%+19.0%$2.06B$445.76M64.25790NTRANatera1.6524 of 5 stars$158.69-1.9%$184.63+16.3%+43.8%$21.67B$1.70B-107.954,434HIMSHims & Hers Health2.0834 of 5 stars$48.34+0.8%$39.58-18.1%+120.7%$10.82B$1.78B70.061,637Trending NewsAnalyst DowngradeInsider TradeOPCHOption Care Health4.5521 of 5 stars$30.91-0.8%$35.50+14.8%+1.7%$5.06B$5.00B24.938,088News CoveragePositive NewsAnalyst ForecastRDNTRadNet4.1881 of 5 stars$55.26-1.7%$69.60+26.0%-9.7%$4.15B$1.83B-128.5111,021News CoveragePositive NewsAnalyst ForecastBTSGBrightSpring Health Services1.7413 of 5 stars$22.00-0.5%$24.90+13.2%+83.6%$3.87B$11.27B78.5735,000SHCSotera Health3.1603 of 5 stars$11.40-2.9%$16.00+40.4%-4.5%$3.24B$1.11B142.523,000SGRYSurgery Partners2.4768 of 5 stars$22.03-0.5%$33.56+52.3%-18.0%$2.82B$3.11B-14.4015,000CONConcentra Group Holdings Parent2.9071 of 5 stars$20.33-1.1%$28.50+40.2%N/A$2.61B$1.90B15.1711,250News CoveragePRVAPrivia Health Group4.504 of 5 stars$21.35-3.4%$27.77+30.1%+14.2%$2.60B$1.80B177.931,140News CoverageAnalyst Forecast Related Companies and Tools Related Companies Veracyte Alternatives Natera Alternatives Hims & Hers Health Alternatives Option Care Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Privia Health Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GH) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardant Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardant Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GH Stock Alerts